Literature DB >> 11106320

Fetal DNA in maternal plasma: biology and diagnostic applications.

Y M Lo1.   

Abstract

BACKGROUND: Molecular analysis of plasma DNA during human pregnancy has led to the discovery that maternal plasma contains both fetal and maternal DNA. This valuable source of fetal DNA opens up new possibilities for noninvasive prenatal diagnosis. APPROACH: Published data from the last 3 years demonstrating the feasibility and utility of analyzing fetal DNA in maternal plasma are reviewed. CONTENT: The detection of fetal DNA in maternal plasma is much simpler and more robust than detecting fetal nucleated cells in maternal blood, and does not require prior enrichment. This approach has been shown to have application in the prenatal diagnosis of fetal rhesus D status, sex-linked disorders, and other paternally inherited genetic disorders. Abnormal fetal DNA concentrations in maternal plasma and serum have been found in common pregnancy-associated disorders, including preterm labor and preeclampsia, as well as in pregnancies complicated by fetal trisomy 21. After delivery, fetal DNA is cleared rapidly from maternal plasma, with a half-life in the order of minutes. These clearance kinetics exhibit an important difference from fetal cell clearance, where long-term persistence has been demonstrated.
SUMMARY: It has been only 3 years since fetal DNA was first detected in maternal plasma, and much remains to be learned about the biology of this phenomenon. In addition, additional diagnostic applications beyond those discussed here can be expected in the near future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106320

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  22 in total

1.  Epigenetic approaches for the detection of fetal DNA in maternal plasma.

Authors:  Dana Wy Tsui; Rossa Wk Chiu; Ym Dennis Lo
Journal:  Chimerism       Date:  2010 Jul-Sep

Review 2.  Non-invasive Prenatal Testing Using Fetal DNA.

Authors:  Giulia Breveglieri; Elisabetta D'Aversa; Alessia Finotti; Monica Borgatti
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

Review 3.  Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.

Authors:  Mary Beth Terry; Jasmine A McDonald; Hui Chen Wu; Sybil Eng; Regina M Santella
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 4.  Recent advances of genomic testing in perinatal medicine.

Authors:  David G Peters; Svetlana A Yatsenko; Urvashi Surti; Aleksandar Rajkovic
Journal:  Semin Perinatol       Date:  2014-11-28       Impact factor: 3.300

Review 5.  Tracking fetal development through molecular analysis of maternal biofluids.

Authors:  Andrea G Edlow; Diana W Bianchi
Journal:  Biochim Biophys Acta       Date:  2012-04-19

6.  Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.

Authors:  Kimberly Bunce; Tianjiao Chu; Urvashi Surti; William Allen Hogge; David G Peters
Journal:  Prenat Diagn       Date:  2012-04-11       Impact factor: 3.050

Review 7.  Noninvasive prenatal testing: the future is now.

Authors:  Errol R Norwitz; Brynn Levy
Journal:  Rev Obstet Gynecol       Date:  2013

8.  Prenatal diagnosis of common aneuploidies in transcervical samples using quantitative fluorescent-PCR analysis.

Authors:  Cecilia Bussani; Riccardo Cioni; Alberto Mattei; Massimiliano Fambrini; Mauro Marchionni; Gianfranco Scarselli
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 9.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

10.  Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

Authors:  Corina Kohler; Ramin Radpour; Zeinab Barekati; Reza Asadollahi; Johannes Bitzer; Edward Wight; Nicole Bürki; Claude Diesch; Wolfgang Holzgreve; Xiao Yan Zhong
Journal:  Mol Cancer       Date:  2009-11-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.